MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1111/coa.14040

Медицинская библиотека · Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery · 2023

Management of epistaxis associated with oral antithrombotic drugs in emergency department and impact on prescription thereafter.

Bouget Jacques, Balusson Frédéric, Roy Pierre-Marie, Viglino Damien, Pavageau Laure, Lacut Karine, Oger Emmanuel

Клиническое исследованиеСтатьяМногоцентровое исследованиеПеревод в очереди

Аннотация

OBJECTIVES

To describe management, and to assess factors associated with antithrombotic prescription thereafter in patients who had epistaxis referred to emergency department (ED).

DESIGN

Prospective cohort study. From EDs, clinical, biological and hospital data were collected. The clinical database was linked to the French Health Insurance Database where we retrieved antithrombotic drug deliveries in a 3-month period before and after referral.

SETTING

Multicentric population-based cohort study within five well-defined areas.

PARTICIPANTS

We considered 306 patients referred for epistaxis with a stable oral antithrombotic regimen before referral.

MAIN OUTCOME MEASURES: We considered management, hospital outcome and case fatality. Antithrombotic prescription in a 3-month follow-up period was categorised into three classes: no change, class change, or discontinuation. During follow-up, hospitalisation for epistaxis or ischaemic events was searched.

RESULTS

Among 306 adult individuals (mean age: 76 years), 166 took oral anticoagulant and 140 an antiplatelet drug. Blood transfusion was needed in 13.7% of patients and anterior packing alone in 61%. Half of the patients were hospitalised; 301 were discharged alive. Considering antithrombotic prescription thereafter we observed no change in 219 patients (72.8%), class changes in 47 patients (15.6%) and discontinuation in 35 patients (11.6%). We identified four independent predictors for antithrombotic prescription: hospitalisation (vs. returning home, p = .05), age (p = .03), haemoglobin level (p = .03) and oral anticoagulant (vs. antiplatelet agent, p < .001). During the 3 months following discharge, 2 thrombotic and 15 bleeding events were identified.

CONCLUSIONS

Epistaxis referred to emergency department had an impact on subsequent antithrombotic prescription.

CLINICAL TRIAL REGISTRATION: Clinical Trials.gov identifier: NCT02886533.

Для цитирования: Bouget Jacques, Balusson Frédéric, Roy Pierre-Marie, Viglino Damien, Pavageau Laure, Lacut Karine, Oger Emmanuel. Management of epistaxis associated with oral antithrombotic drugs in emergency department and impact on prescription thereafter.. Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery. 2023. DOI: 10.1111/coa.14040.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.